
Renovacor
Renovacor, headquartered in Philadelphia, is a preclinical‑stage biopharmaceutical company focused on developing transformative gene therapy‑based treatments for cardiovascular disease.
This post is for subscribers only
SubscribeAlready have an account? Log in